Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic

Helse Nord-Trøndelag HF150 enrolled

Overview

Alcohol abuse is associated with a variety of clinical diseases, but studies on prevalence of different somatic diseases among alcohol abusers are lacking. Studies on populations in an out-day patients' clinic are also lacking. The investigators aim to study somatic health standard in an out-day patients' clinic population of alcohol abusers, with regard to prevalence of different kinds of somatic diseases, and how the interaction of somatic and psychiatric treatment can influence on patients quality of life. Clinical examination including blood samples and echocardiographic examinations in all participants, other additional examinations (as x-ray, CT or MRI if indicated by clinical findings).

Retrospective methods will be used to study former somatic disease, cross-section design to study present somatic disease and prospective design to study quality of life, psychiatric and somatic health after combination of psychiatric and somatic examinations and treatment.

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

HEART DISEASE Liver Failure DEPRESSIVE DISORDER Alcoholic Neuropathy

Interventions

Patients referred to the clinic will be given optimal treatment for revealed psychiatric and/or somatic disease including conversational therapy, and if indicated therapeutic interventions with respect to any kind of disease.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Alcohol abusers reffered to the out-day patients' clinic at Dep. of Psychiatry, Levanger Hospital, Norway Exclusion Criteria: * Not consenting to participate * Not able to consent

Locations (1)

Levanger Hospital, Dep. of Psychiatry

Levanger, Norway

Outcomes

Primary Outcomes

Prevalence of different kinds of somatic disease

Prevalence of somatic disease at study attendance of any kind, specified for heart disease, gall- and liver disease, neuropathic disease.

Time frame: 3 months after inclusion

Secondary Outcomes

Prevalence of former somatic disease

Prevalence of former somatic disease investigated by anamnestic examination, search in patient journals and communication with the patients community health service.

Time frame: 3 months after inclusion

Outcome of psychiatric and somatic treatment of alcohol abusers

Quality of life and score of somatic and psychiatric health 1 year after inclusion

Time frame: 1 year after stopped inclusion

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.